CD4 and cancer: In particular, we identified that TCF-1loT-bethi cytotoxic CD4+ TBYS cells conveyed GzmB-dependent cytotoxicity and were amenable to OV-BYTE-mediated therapeutic effects, thus being aligned with the recently highlighted cytotoxic functions of CD4+ T cells in eliminating cancer cells47 and virus-infected cells48.